Gene Query: DYNLL1

Dataset Description Geneva Score
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 88.8
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 45.19
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 42.56
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 42.11
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 40.96
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 38.47
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 32.99
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 30.41
Ebola virus (EBOV) infection of ARPE-19 cells 28.73
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 27.15
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 27.07
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 26.45
FOXD3 is a novel tumor suppressor in lung cancer 26.03
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 25.27
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 25.19
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 25.07
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 24.8
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 24.6
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 24.6
Effect of FGF13 depletion on the H460 cell line 24.38
RNA sequencing of GlyH-101-treated MCF-7 cell line 23.8
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 22.86
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 21.6
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 21.27
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 21.24
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 21.24
Transcriptomic analysis of human tonsillar TFH subsets 21.08
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 20.64
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 20.61
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 20.54
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 20.44
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 20.35
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 19.84
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 19.76
Transcriptional profile in human S. haematobium infection 19.16
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 18.43
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 17.99
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 17.99
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 17.85
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 17.85
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 17.77
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 17.19
Human HAP1 cells before and after nutrient deprivation 17.19
Systematic discovery of endogenous human ribonucleoprotein complexes 17.1
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 17.08
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 16.69
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 16.62
Differentiation enhances Zika virus infection in neuronal brain cells 16.43
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 16.29
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 16.14
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.98
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 15.95
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 15.95
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 15.48
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 15.41
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 15.36
Novel Targeting of Transcription and Metabolism in Glioblastoma 15.21
EWSR1 influences alternative splicing through direct and indirect mechanisms 15.19
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 15.16
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 15.02
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 14.85
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 14.73
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 14.72
Role of microRNAs in the interaction between Salmonella and the host cell 14.7
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 14.59
RNA-Seq with and without RNase treatment in PCa cell lines 14.56
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 14.55
Identification of global regulators of T-helper cell lineage specification 14.35
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 14.35
Widespread intronic polyadenylation diversifies immune cell transcriptomes 14.32
Role of cervicovaginal microbiota in genital inflammation 14.11
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 14.1
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 14.02
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 13.98
4sU-seq of HFF exposed to salt and heat stress 13.97
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 13.96
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 13.92
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 13.8
Gene expression profile of human iPSC-derived nephron progenitor cells 13.77
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 13.65
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 13.61
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 13.61
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 13.59
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 13.47
Global analysis of enhancer targets: Mosaic-seq 13.37
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 13.32
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 13.29
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 13.23
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 13.19
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 13.19
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.08
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 13.03
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.87
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 12.75
An integrative analysis of non-coding regulatory DNA variations associated with autism 12.75
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 12.73
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.72
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 12.7
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 12.66
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 12.46
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 12.43
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 12.25
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 12.25
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 12.02
3’ Uridylation Expands miRNA Target Repertoire 11.94
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.92
Rorc disruption in human FG pancreatic cancer cells 11.83
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 11.8
Mitochondrial dsRNA triggers antiviral signalling in humans 11.77
Total RNA-seq in ALL-SIL upon TLX1 knockdown 11.73
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 11.68
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 11.66
The human blood-nerve barrier transcriptome 11.58
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 11.54
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 11.54
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 11.53
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 11.53
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 11.52
NRDE2 negatively regulates nuclear exosome functions 11.43
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 11.42
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 11.42
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 11.42
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.4
CROP-Seq in Primary Human T Cells 11.37
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 11.37
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 11.29
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 11.24
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 11.17
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.17
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 11.15
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 11.15
Transcriptomic analysis of the HOTAIR-regulated genes 11.14
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 11.12
Identification of Atrial Fibrillation associated genes and functional non-coding variants 10.92
Transcriptional profiles of normal human mature B cells 10.9
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 10.74
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 10.73
Unique features and clinical importance of acute alloreactive immune responses 10.69
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 10.68
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 10.66
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 10.59
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 10.59
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 10.52
Accurate annotation of human protein-coding small open reading frames 10.47
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 10.4
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.35
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 10.28
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 10.2
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 10.12
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.08
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 10.06
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 10.05
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 10.05
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 10.05
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 9.97
Reassessment of Exosome Composition 9.97
Gene expression changes caused by KRAS in MCF-10A 9.94
RNA-seq of resting and activated CD4+ T cells +-JQ1 9.9
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 9.8
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 9.8
Identification of transcription start sites for human A549 cell line using ReCappable-seq 9.78
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 9.74
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.71
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 9.69
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 9.61
Gene expression analysis of dengue-infected cells 9.59
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 9.55
The evolution of N6-methyladenosine in primates 9.49
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 9.49
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 9.37
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 9.36
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 9.35
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.35
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 9.35
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 9.32
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.23
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 9.21
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.16
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 9.14
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 9.14
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 9.09
Mechanistic Model-Guided Study of Embryonic Morphogenesis 9.08
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 9.08
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 9.04
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.03
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.03
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.03
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 9.01
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 8.96
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 8.91
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.9
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 8.87
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.87
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 8.86
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.82
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 8.71
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 8.67
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 8.67
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 8.66
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 8.64
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 8.63
LncRNA expression profiling of ischemic stroke patients 8.6
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 8.57
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 8.55
Transcriptome analysis of human lung epithelial cells 8.54
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 8.54
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 8.51
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.46
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 8.46
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.43
Landscape and variation of RNA secondary structure across the human transcriptome 8.37
FBXW7 modulates stress response by post-translational modification of HSF1 8.33
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 8.33
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 8.31
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 8.31
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 8.3
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 8.25
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 8.21
mRNA expression profile of Lymphocytes 8.21
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.2
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.2
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 8.16
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 8.14
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.1
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 8.09
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 8.04
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 8.02
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 8.02
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 7.95
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 7.91
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 7.91
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 7.91
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 7.9
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.88
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 7.79
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 7.76
LIN28A Over-expression RNAseq 7.74
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 7.73
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 7.73
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 7.73
Polarized B -cell functions 7.62
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.59
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 7.58
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.56
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 7.52
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 7.4
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.4
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.37
mRNA expression in human DAOY cells 7.33
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 7.17
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 7.16
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 7.12
7.04
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.98
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.98
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.98
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 6.96
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 6.96
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.96
Controlling for gene expression changes in transcription factor protein networks. 6.95
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 6.92
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 6.91
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.9
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.9
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.86
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 6.86
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 6.72
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 6.71
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 6.71
Proliferation-correlated expression 6.71
The age and genomic integrity of neurons after cortical stroke in humans 6.69
RNA editing in nascent RNA affects pre-mRNA splicing 6.63
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 6.58
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 6.53
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.52
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 6.5
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 6.5
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 6.49
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 6.38
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 6.38
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 6.34
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.32
SLAM-seq for K562 endogenous mRNA decay 6.23
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 6.22
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 6.16
Gene expression analysis upon mtDNA depletion 6.15
Gene expression analysis upon mtDNA depletion [RNA-seq] 6.15
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 6.12
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 6.08
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 5.93
RNA-seq data 5.92
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 5.91
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 5.88
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 5.86
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 5.86
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 5.73
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 5.7
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 5.7
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 5.65
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 5.44
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.38
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 5.38
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.37
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.34
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.21
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 5.18
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 5.18
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 5.18
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.17
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.13
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 5.06
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.99
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.99
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.83
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.83
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.83
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.77
Metastasis in triple-negative breast cancer 4.71
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 4.71
RNAseq in Alzheimer's Disease patients 4.68
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 4.66
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.64
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 4.61
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.54
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.54
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.52
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.52
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.46
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 4.39
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 4.39
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 4.37
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 4.26
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.23
Transcriptional landscape changes during human embryonic stem cell derivation 4.2
A single-cell transcriptome atlas of the human pancreas 4.19
CD74 role in transcription regulation 4.17
CD74 role in transcription regulation [RNA-seq] 4.17
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 4.1
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 4.1
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.98
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 3.96
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.93
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.93
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 3.92
Specific molecular signatures underlie response to decitabine in CMML 3.92
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.8
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 3.74
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 3.74
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.73
Ribosome profiling upon inhibition of eIF4A 3.63
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.59
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 3.59
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 3.59
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.59
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 3.58
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.47
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.43
miR-93 Targets in Human Endothelial Cells 3.4
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.35
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.32
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.32
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.32
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 3.24
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.18
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 3.11
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 3.11
Exogenous rescue of KLHL9 in SF210 cell line 3.06
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 2.95
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 2.95
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.94
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.82
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 2.72
Effect of BMP inhibition or stimulation of primary human keratinocytes 2.72
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.7
NR2F2 study 2.69
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.69
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.66
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.66
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 2.61
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 2.54
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 2.54
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.53
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 2.52
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.41
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.4
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.38
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.31
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.3
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.28
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.28
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.27
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.25
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.25
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.23
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.23
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.23
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.21
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.2
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.2
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.2
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.18
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.16
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.14
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.14
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.13
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.07
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.96
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.96
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.95
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.79
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.79
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.78
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.71
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.68
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.66
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.64
Determining mRNA half-lives on a transcriptome-wide scale 1.61
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.6
Dermal endothelial cells of type 2 diabetic patients 1.59
Alagille_Nodder 1.55
RNA Seq of Alagille liver biopsies 1.55
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 1.55
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.51
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 1.5
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.49
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.49
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.48
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.4
Metabolism as an early predictor of DPSCs aging 1.39
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.36
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.36
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.34
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.33
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.29
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.29
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.25
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 1.24
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.21
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.11
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.07
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.05
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.93
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.92
Solid phase chemistry to covalently and reversibly capture thiolated RNA 0.92
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.87
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.87
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.84
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.84
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 0.83
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.82
Anti-inflammatory effect of indoleacrylic acid (IA) 0.82
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.8
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.8
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.76
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.74
Gene expression alterations of pancreatic intraepithlial neoplasia 0.66
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.64
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.61
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.61
iPSC derived motor neuron cultures from C9ORF72 carriers 0.6
Global transcriptome analysis of WT versus HEB-/- hESCs 0.6
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.54
High-resolution comparative analysis of great ape genomes 0.5
Transcriptome-wide response to synthetic chromatin protein PcTF 0.49
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.47
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.44
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.44
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.43
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.35
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.35
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.33
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.3
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.3
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.28
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.26
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.24
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.23
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.23
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.17
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.16
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.16
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.16
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 0.15
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 0.15
Transcription elongation regulates genome 3D structure 0.14
hESC neural differentiation 0.12
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.12
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.12
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.1
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.08
siRNA-mediated knockdown 0.08
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.06
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.05
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.03
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.0
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.0
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation